Genelux Corp (GNLX)

Dec 18, 2024

Genelux CEO Zindrick Thomas sells $33,497 in stock - Investing.com

Dec 18, 2024

Dec 18, 2024

Genelux CEO Zindrick Thomas sells $33,497 in stock By Investing.com - Investing.com UK

Dec 18, 2024

Dec 13, 2024

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - Yahoo Finance

Dec 13, 2024

Nov 19, 2024

HC Wainwright Cuts Genelux (NASDAQ:GNLX) Price Target to $30.00 - Defense World

Nov 19, 2024

Nov 15, 2024

Genelux shares target cut, maintains buy rating on 3Q earnings - Investing.com

Nov 15, 2024

Nov 14, 2024

Genelux reports Q3 EPS (19c), consensus (19c) - TipRanks

Nov 14, 2024

Nov 14, 2024

Genelux Reports $6.5M Q3 Loss, Advances Lung Cancer Trials with $35.1M Cash Runway - StockTitan

Nov 14, 2024

Nov 08, 2024

Genelux Corp. Releases New Corporate Presentation - TipRanks

Nov 08, 2024

Nov 06, 2024

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Genelux CEO to Present at Guggenheim Healthcare Innovation Conference - StockTitan

Nov 06, 2024

Oct 31, 2024

Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Guggenheim Begins Coverage on Genelux (NASDAQ:GNLX) - Defense World

Oct 31, 2024

Oct 29, 2024

Guggenheim sees upside in Genelux shares, targets $8 as pivotal cancer trial progresses - Investing.com India

Oct 29, 2024

Oct 29, 2024

Brokerages Set Genelux Co. (NASDAQ:GNLX) PT at $22.33 - MarketBeat

Oct 29, 2024

Oct 25, 2024

Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp - Yahoo Finance

Oct 25, 2024

Oct 23, 2024

Genelux doses first subject in Phase II trial of NSCLC treatment - Yahoo Finance

Oct 23, 2024

Oct 22, 2024

Genelux advances NSCLC treatment with Phase 2 Olvi-Vec trial - Investing.com

Oct 22, 2024

Oct 22, 2024

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - Yahoo Finance

Oct 22, 2024

Oct 17, 2024

Cubist Systematic Strategies LLC Takes $56,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 17, 2024

Oct 14, 2024

Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 14, 2024

Oct 09, 2024

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - Yahoo Finance

Oct 09, 2024

Oct 04, 2024

Genelux announces executive departure By Investing.com - Investing.com Australia

Oct 04, 2024

Oct 03, 2024

Genelux announces executive departure - Investing.com

Oct 03, 2024

Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Acquires Shares of 20,162 Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 01, 2024

Sep 25, 2024

Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 25, 2024

Sep 19, 2024

Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 19, 2024

Sep 18, 2024

Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat

Sep 18, 2024

Sep 14, 2024

Genelux corp insider sells over $170k in company stock - Investing.com India

Sep 14, 2024

Sep 12, 2024

Genelux director Tyree James L sells shares worth over $4,400 - Investing.com India

Sep 12, 2024

Sep 11, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in Stock - MarketBeat

Sep 11, 2024

Sep 11, 2024

Genelux corp insider sells over $196k in company stock - Investing.com

Sep 11, 2024

Sep 11, 2024

ROTH MKM analysts initates a Buy rating for Genelux Corp (GNLX) - Knox Daily

Sep 11, 2024

Sep 07, 2024

Genelux Corp insider sells $89.6k in company stock By Investing.com - Investing.com Australia

Sep 07, 2024

Sep 06, 2024

Genelux Corp insider sells $89.6k in company stock - Investing.com India

Sep 06, 2024

Sep 06, 2024

Insider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of Stock - MarketBeat

Sep 06, 2024

Sep 06, 2024

Genelux Corp [NASDAQ: GNLX] Sees Increase in Stock Value - Knox Daily

Sep 06, 2024

Sep 06, 2024

Genelux Corp (GNLX) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 06, 2024

Sep 03, 2024

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance

Sep 03, 2024

Sep 02, 2024

Genelux Corp (GNLX) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 02, 2024

Sep 01, 2024

Aladar Szalay Sells 107,045 Shares of Genelux Co. (NASDAQ:GNLX) Stock - Defense World

Sep 01, 2024

Aug 31, 2024

Genelux Corp insider sells over $550k in company stock - Investing.com India

Aug 31, 2024

Aug 29, 2024

Analysts Set Genelux Co. (NASDAQ:GNLX) Price Target at $26.75 - MarketBeat

Aug 29, 2024

Aug 29, 2024

Genelux (NASDAQ:GNLX) Upgraded to Strong-Buy by Roth Capital - Defense World

Aug 29, 2024

Aug 28, 2024

Genelux Corp [GNLX] Insider Activity: An Update for Investors - Knox Daily

Aug 28, 2024

Aug 28, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 40,000 Shares - Defense World

Aug 28, 2024

Aug 28, 2024

Genelux (NASDAQ:GNLX) Receives New Coverage from Analysts at Roth Mkm - Defense World

Aug 28, 2024

Aug 27, 2024

Genelux (NASDAQ:GNLX) Coverage Initiated at Roth Mkm - MarketBeat

Aug 27, 2024

Aug 27, 2024

Genelux shares gain on Roth/MKM Buy rating, $10 price target - Investing.com

Aug 27, 2024

Aug 27, 2024

Genelux initiated with a Buy at Roth MKM - TipRanks

Aug 27, 2024

Aug 19, 2024

Equities Analysts Offer Predictions for Genelux Co.’s Q3 2024 Earnings (NASDAQ:GNLX) - Defense World

Aug 19, 2024

Aug 18, 2024

Genelux Co. (NASDAQ:GNLX) Sees Large Decrease in Short Interest - MarketBeat

Aug 18, 2024

Aug 17, 2024

Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Yahoo Finance

Aug 17, 2024